Recent Updates
Recently added Catalysts
NUVL Positive Sentiment Score: 70/100

Nuvalent to Participate in the TD Cowen 4th Annual Oncology Innovation Summit Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...

Wednesday, May 24, 2023 1 min read
Key Takeaway: Nuvalent, Inc. will participate in the TD Cowen 4th Annual Oncology Innovation Summit, scheduled for May 31, 2023. CEO James Porter and CFO Alexandra Balcom will engage in a fireside chat, aiming to showcase the company's targeted cancer therapies. A live webcast will be available for those unable to attend in person, indicating the company's commitment to maintaining investor engagement. This participation underscores Nuvalent's positioning within the oncology space and highlights their focused development strategies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a significant oncology summit reflects the company's increasing visibility.
  • Key leadership will present, highlighting confidence in their therapeutic developments.
  • Opportunities for networking and collaboration with other innovators in oncology.

Full Press Release Details

CAMBRIDGE, Mass. , May 24, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL ), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter , Ph.D., Chief Executive Officer, and Alexandra Balcom , Chief Financial Officer, will participate in a fireside chat during the TD Cowen 4th Annual Oncology Innovation Summit on Wednesday, May 31, 2023 , at 10:30 a.m. ET .
A live webcast will be available in the Investors section of the company's website at www.nuvalent.com , and archived for 30 days following the presentation.
SOURCE Nuvalent, Inc.

21 %

Frequently Asked Questions

When will Nuvalent participate in the Oncology Innovation Summit?

Nuvalent will participate on May 31, 2023, at 10:30 a.m. ET.

Who will represent Nuvalent at the event?

James Porter, Ph.D., and Alexandra Balcom will represent Nuvalent.

Where can I watch the Nuvalent presentation?

You can watch it live in the Investors section of Nuvalent's website.

Will the webcast be available after the event?

Yes, the webcast will be archived for 30 days post-presentation.

Tags: NUVL Viatris Investor Conferences Healthcare Nuvalent oncology TD Cowen cancer therapies biopharmaceutical
Last updated: May 24, 2023